Sector valuations Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.000 USD | +1.01% |
|
+3.09% | +9.09% |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -2.7x | 1.33x | 0.13x | 409.23x | -1.22x | -1.24x | -.--% | 342M | |
| 33.6x | 4.47x | 1.29x | 6x | 17.84x | 25.1x | 0.95% | 49.47B | |
| -21.84x | 21.43x | -0.38x | 315.86x | -21.6x | -20.97x | -.--% | 43.97B | |
| 46.07x | 7.45x | 0.23x | 5.25x | 28.89x | 33.29x | -.--% | 39.6B | |
| 30.74x | 5.61x | -32.2x | 3.05x | 13.16x | 19.89x | -.--% | 39.29B | |
| 30.33x | 2.46x | 0.63x | 8.75x | 21.99x | 26.19x | 0.38% | 32.43B | |
| 33.59x | 24.1x | 2.23x | 5.5x | 24.99x | 26.14x | -.--% | 16.49B | |
| 23.22x | 2.6x | 0.67x | 2.04x | 8.82x | 13.52x | 1.16% | 14.01B | |
| 65.72x | 4.24x | -0.27x | 3.81x | 14.73x | 18.14x | -.--% | 12.77B | |
| 27.87x | 1.32x | 0.27x | 1.87x | 11.48x | 13.07x | -.--% | 12.69B | |
| -32.17x | 9.47x | 1.21x | 116.56x | -33.18x | -57.74x | -.--% | 11.37B | |
| 60.75x | 5.19x | 0.38x | 9.26x | 26.32x | 28.75x | 0.44% | 11.26B | |
| 42.2x | 4.65x | 2.96x | 4.88x | 20.53x | 32.42x | 0.53% | 11.17B | |
| -31.24x | 9.04x | -13.72x | 1005.85x | -26.67x | -26.13x | -.--% | 10.12B | |
| -26.19x | 8.97x | -12x | 8827.82x | -21.46x | -20.89x | -.--% | 10.07B | |
| 31.41x | - | -0.1x | 16.33x | 40.07x | 30.71x | -.--% | 9.44B | |
| -15.83x | 654.78x | -0.32x | 9.78x | -16.05x | -15.27x | -.--% | 9.4B | |
| -36.49x | 19.09x | -31.18x | 6.21x | 152.1x | -2023.87x | -.--% | 9.39B | |
| -28.32x | 8.07x | -9.79x | 72.24x | -18.8x | -17.91x | -.--% | 8.94B | |
| Average | 12.14x | 44.13x | -4.73x | 570.02x | 12.73x | -100.88x | 0.18% | 18.54B | |
| Weighted average by Cap. | 18.60x | 26.46x | -4.93x | 331.21x | 12.28x | -43.10x | 0.25% |
- Stock Market
- Stocks
- CATX Stock
- Sector Perspective Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
